Avoid Problems With the New, Injectable Aimovig for Migraine Prevention

August 2018

You'll hear buzz about Aimovig (AIM-oh-vig, erenumab), a new, injectable biologic to PREVENT migraine in adults.

Aimovig blocks the calcitonin gene-related peptide (CGRP) receptor...to help decrease migraine attacks. More of these "CGRP antagonists" will likely be approved within a few months.

Expect Aimovig to be saved for when patients don't respond to, or can't tolerate, first-line meds for preventing migraine...such as beta-blockers (propranolol, etc), topiramate, or valproate.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Injectables Safeguard Against Accidental IV Administration of Certain Meds
Compounding Ensure Your Pharmacy's Compounding Recipes Are Up to Par
Chemotherapy Use Strategies to Keep Your Oncology Patients Safe
Hospital Practice Know the Differences Between Smoflipid and Traditional IV Lipids
Liver Disease Prevent Mix-Ups With Meds for Spontaneous Bacterial Peritonitis
Opioids Ask for Specific Details About Opioid Reactions
Migraine Avoid Problems With the New, Injectable Aimovig for Migraine Prevention
Antibiotics Make Sure Your Patients Get the Right Nitrofurantoin Product
Kidney Disease Help Chronic Kidney Disease Patients Reduce Itching

Avoid Problems With the New, Injectable Aimovig for Migraine Prevention

Practical advice for a better career, with unlimited access to CE

Table of Contents